Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Alopecia treatment should use a modern, combined approach to effectively address hair loss.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Minoxidil helps hair growth by activating the β-catenin pathway.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

New treatments for male hypogonadism are effective and should be personalized.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.